Surgery – Diagnostic testing – Detecting nuclear – electromagnetic – or ultrasonic radiation
Reexamination Certificate
2000-09-18
2004-07-20
Leung, Philip H. (Department: 3742)
Surgery
Diagnostic testing
Detecting nuclear, electromagnetic, or ultrasonic radiation
C600S476000, C600S504000
Reexamination Certificate
active
06766187
ABSTRACT:
TECHNICAL FIELD OF THE INVENTION
The present invention relates in general to laser treatment of biological tissues and structures including blood vessels. The invention relates in particular to methods of detecting onset of coagulation in the blood vessels.
DISCUSSION OF BACKGROUND ART
In recent years, use of lasers for treatment of dermatological conditions and other conditions involving blood vessels has rapidly gained acceptance by the medical community. By way of example, lasers delivering light in the green and yellow regions of the visible spectrum are now effectively used to treat vascular disorders. The green and yellow wavelengths between about 530 and 590 nanometers (nm) are particularly favored because absorption of these wavelengths in blood hemoglobin is significantly higher than in the skin pigment melanin. This allows the hemoglobin to be selectively targeted by the radiation in a treatment often referred to as selective photothermolysis. In such a treatment, blood in targeted vessels is coagulated by heat generated when the green or yellow light is absorbed in the blood hemoglobin. This results in necrosis of the vessels in the treated area. The coagulated or necrotized vessels are eventually reabsorbed by the body and replaced with scar tissue.
One problem encountered in applying laser treatment is determining a light dosage sufficient to effect the required coagulation. This can vary from patient to patient depending on factors such as melanin content of the skin (skin color), the size (diameter) of blood vessels being treated and the depth of the blood vessels in the skin. Extending dosage beyond that required to effect coagulation can lead to complications including scarring, scabbing, edema and epidermal damage or extravasation of red blood cells from a vessel being treated. Extravasation can lead to formation of progressive purpura which will eventually disappear, but which are generally cosmetically unacceptable to patients under most circumstances.
An increase in reflection and scatter of treatment radiation has been observed in connection with lesion formation in retinal photocoagulation. Skin, however, is highly scattering of yellow/green radiation. Accordingly any increase in reflection or scatter resulting from coagulation of blood in a blood vessel in or under the skin will be difficult to discriminate from background scatter and reflection. Accordingly there is need for a method of detecting the onset of coagulation which effectively discriminates against background scatter and reflection of treatment radiation.
SUMMARY OF THE INVENTION
The present invention is directed to a method of detecting onset of coagulation of blood in a blood vessel irradiated by electromagnetic radiation having a selected treatment wavelength. The method comprises directing electromagnetic radiation having a selected monitoring wavelength to the blood vessel, the monitoring wavelength being different from the treatment wavelength. A portion of the monitoring radiation remitted from the blood vessel is detected. One of an increase and decrease in the detected remitted monitoring radiation is interpreted as an indication of the onset of coagulation of blood in the blood vessel.
The method of the present invention is based on detecting a change in absorptivity of blood irradiated by the treatment wavelength characteristic of conversion of oxyhemoglobin and de-oxyhemoglobin in the normal blood to methemoglobin. Depending on the wavelength the absorptivity of methemoglobin can be higher or lower than the absorptivity of normal blood. By way of example, in a wavelength range between about 525 and 580, methemoglobin has a lower absorptivity than normal blood. In wavelength ranges between about 610 and 660 nm and between about 800 and 1000 nm, methemoglobin has a higher absorptivity than normal blood.
In one preferred embodiment of the inventive method, the monitoring wavelength is selected such that the absorptivity thereof in normal blood is greater than or equal to about two times the absorptivity thereof in methemoglobin, and an increase in the detected remitted monitoring radiation is interpreted as an indication of the onset of coagulation of blood in the blood vessel. In another preferred embodiment of the inventive method, the monitoring wavelength is selected such that the absorptivity thereof in normal blood is less than or equal to about one-half the absorptivity thereof in methemoglobin, and a decrease in the detected remitted monitoring radiation is interpreted as an indication of the onset of coagulation of blood in the blood vessel.
One application of the method of the present invention is in dermal treatments wherein the wavelength of treatment radiation is in a range between about 510 and 585 nm, for example, the 532 nm radiation of a frequency-doubled Nd:YAG laser. Here, a preferred monitoring wavelength is selected in a range between about 610 and 660 nm.
REFERENCES:
patent: 4773097 (1988-09-01), Suzuki et al.
patent: 6165170 (2000-12-01), Wynne et al.
patent: 6289236 (2001-09-01), Koenig et al.
patent: 6505059 (2003-01-01), Kollias et al.
patent: 6522911 (2003-02-01), Toida et al.
patent: 56-137140 (1981-10-01), None
patent: 60-006871 (1985-01-01), None
O. Pomerantzeff et al., “A Method to Predetermine the Correct Photocoagulation Dosage,”Arch Ophthalmol,vol. 101, Jun. 1983, pp. 949-953.
J.H.C. Inderfurth et al., “Dynamic Reflectometer for Control of Laser Photocoagulation on the Retina,”Lasers in Surgery and Medicine,vol. 15, No. 1, 1994, pp. 54-61.
Y. Yang et al., “Automatic Control of Lesion Size in a Simulated Model of the Eye,”IEEE Journal of Quantum Electronics,vol. 26, No. 12, Dec. 1990, pp. 2232-2239.
M.R. Jerath et al., “Reflectance Feedback Control of Photocoagulation In Vivo,”Arch Ophthalmol,vol. 111, Apr. 1993, pp. 531-534.
W.J. Geeraets et al., “Light Reflectance of the Ocular Fundus,”Archives of Ophthalmology,vol. 69, May 1963, pp. 612-617.
W.S. Weinberg et al., “The Change in Light Reflection of the Retina During Therapeutic Laser-Photocoagulation,”IEEE Journal of Quantum Electronics,vol. QE-20, No. 12, Dec. 1984, pp. 1481-1489.
R. Birngruber et al., “Fundus Reflectometry: A Step towards Optimization of the Retina Photocoagulation,”Mod. Probl. Ophthal.,vol. 18, 1977, pp. 383-390.
M.R. Jerath et al., “Calibrated real-time control for lesion size based on reflectance images,”Applied Optics,vol. 32, No. 7, Mar. 1, 1993, pp. 1200-1209.
O. Pomerantzeff et al., “Time and Location Analysis of Lesion Formation in Photocoagulation,”Arch Ophthalmol,vol. 101, Jun. 1983, pp. 954-957.
D.J. Smithies et al., “The Effect of the Illumination Time When Treating Port-wine Stains,”Lasers in Medical Science,vol. 10, No. 2, Jun. 1995, pp. 93-104.
S. Gabay et al., “Modelling the Assessment of Port Wine Stain Parameters From Skin Surface Temperature Following a Diagnostic Laser Pulse,”Lasers in Surgery and Medicine,vol. 20, No. 2, 1997, pp. 179-187.
C.H.G. Wright et al., “Initial in vivo results of hybrid retinal photocoagulation system,”Journal of Biomedical Optics,vol. 5, No. 1, Jan. 2000, pp. 56-61.
S. Mordon et al., “Relation Between Skin Surface Temperature and Minimal Blanching During Argon, Nd-YAG 532, and CW Dye 585 Laser Therapy of Port-Wine Stains,”Lasers in Surgery and Medicine,vol. 13, No. 1, 1993, pp. 124-126.
G.D. Lewis et al., “Backscattering target detection in a turbid medium by polarization discrimination,”Applied Optics,vol. 38, No. 18, Jun. 20, 1999, pp. 3937-3944.
T.E. Milner et al., “Depth determination of chromophores in human skin by pulsed photothermal radiometry,”Applied Optics,vol. 35, No. 19, Jul. 1, 1996, pp. 3379-3385.
R.R. Anderson et al., “Pulsed photothermal radiometry in turbid media: internal reflection of backscattered radiation strongly influences optical dosimetry,”Applied Optics,vol. 28, No. 12, Jun. 15, 1989, pp. 2256-2262.
A. Kienle et al., “Why do veins appear blue? A new look at an old question,”Applied Optics,vol. 35, No. 7, Mar. 1, 1996, pp. 1151-1160.
T.E. Milner et al., “Depth profiling of laser-heated chromophor
Barton Jennifer K.
Black John F.
Eitan, Pearl, Latzer & Cohen Zedek LLP
Leung Philip H.
Lumenis Inc.
LandOfFree
Method for detecting coagulation in laser treatment of blood... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for detecting coagulation in laser treatment of blood..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for detecting coagulation in laser treatment of blood... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3246703